Hansa Biopharma AB recognizes a write-up of SEK 1.430 billion in intangible assets related to Idefirix in the financial
LUND, Sweden, July 4, 2023 /PRNewswire/ -- Hansa Biopharma AB (publ.) (Nasdaq Stockholm: HNSA), a pioneer in...
Source: notimerica.com